Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
UBS
Argus Health
Deloitte
Daiichi Sankyo
Moodys
Harvard Business School
Cantor Fitzgerald
Accenture

Generated: December 15, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PENTOSAN POLYSULFATE SODIUM

« Back to Dashboard

Clinical Trials for pentosan polysulfate sodium

Trial ID Title Status Sponsor Phase Summary
NCT00003825 Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy Completed National Cancer Institute (NCI) Phase 3 RATIONALE: Pentosan polysulfate may be effective in treating side effects of radiation therapy to the abdomen or pelvis. It is not yet known whether pentosan polysulfate is more effective than no further therapy for treating gastrointestinal disturbance caused by previous radiation therapy. PURPOSE: Randomized phase III trial to determine the effectiveness of pentosan polysulfate in treating patients who have inflammation of the rectum, diarrhea, or blood in stools caused by previous radiation therapy to the abdomen and pelvis.
NCT00003825 Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy Completed Radiation Therapy Oncology Group Phase 3 RATIONALE: Pentosan polysulfate may be effective in treating side effects of radiation therapy to the abdomen or pelvis. It is not yet known whether pentosan polysulfate is more effective than no further therapy for treating gastrointestinal disturbance caused by previous radiation therapy. PURPOSE: Randomized phase III trial to determine the effectiveness of pentosan polysulfate in treating patients who have inflammation of the rectum, diarrhea, or blood in stools caused by previous radiation therapy to the abdomen and pelvis.
NCT00086684 Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis Terminated Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Phase 4 The purpose of this study is to evaluate the safety and effectiveness of pentosan polysulfate sodium 100 mg once a day, pentosan polysulfate sodium 100 mg three times a day, and placebo for 24 weeks for the relief of bladder pain or discomfort associated with interstitial cystitis.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for pentosan polysulfate sodium

Condition Name

Condition Name for pentosan polysulfate sodium
Intervention Trials
Interstitial Cystitis 2
Bipolar Disorder 1
Schizoaffective Disorder 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for pentosan polysulfate sodium
Intervention Trials
Cystitis, Interstitial 2
Cystitis 2
Disease 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for pentosan polysulfate sodium

Trials by Country

Trials by Country for pentosan polysulfate sodium
Location Trials
United States 73
Canada 13
Brazil 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for pentosan polysulfate sodium
Location Trials
New York 3
Texas 3
Wisconsin 2
Colorado 2
Tennessee 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for pentosan polysulfate sodium

Clinical Trial Phase

Clinical Trial Phase for pentosan polysulfate sodium
Clinical Trial Phase Trials
Phase 4 2
Phase 3 1
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for pentosan polysulfate sodium
Clinical Trial Phase Trials
Completed 3
Enrolling by invitation 1
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for pentosan polysulfate sodium

Sponsor Name

Sponsor Name for pentosan polysulfate sodium
Sponsor Trials
Federal University of São Paulo 1
National Cancer Institute (NCI) 1
Fundação de Amparo à Pesquisa do Estado de São Paulo 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for pentosan polysulfate sodium
Sponsor Trials
Other 5
Industry 3
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Healthtrust
AstraZeneca
Colorcon
Moodys
Queensland Health
Johnson and Johnson
Argus Health
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.